Children who are given the FluMist nasal vaccine are 55 percent less likely to succumb to the flu than those who get the shot, according to a study in the New England Journal of Medicine today.
Funded by Gaithersburg?s MedImmune ? the maker of FluMist ? the St. Louis University study enlisted 8,475 children ages 6 months to 5 years in 16 countries.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.